Withdrawal syndrome associated with abrupt discontinuation of SSRIs.
Wincor
M Z
MZ
School of Pharmacy, University of Southern California, Los Angeles, USA.
D000328:Adult; D001007:Anxiety / Q000139:chemically induced; D004244:Dizziness / Q000139:chemically induced; D005260:Female; D006801:Humans; D017374:Paroxetine / Q000009:adverse effects*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D013375:Substance Withdrawal Syndrome
D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors